A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India

Journal of Association of Physicians of India

Volumn 51, Issue SEP, 2003, Pages 877-879

  Gogtay, N J ^a   Kadam, V S ^a   Desai, S ^a   Kamtekar, K D ^a   Dalvi, S S ^a   Kshirsagar, N A ^a  

^a BYL NAIR CHARITABLE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; CHLOROQUINE; FLUORENE DERIVATIVE; MEFLOQUINE; SESQUITERPENE;

ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FEMALE; HOSPITALIZATION; HUMAN; INDIA; MALARIA FALCIPARUM; MALE; PHARMACOECONOMICS;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; ECONOMICS, PHARMACEUTICAL; FEMALE; FLUORENES; HOSPITALIZATION; HUMANS; INDIA; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; SESQUITERPENES;

EID: 1242286962     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Engers HD, Godal T. Malaria vaccine development: current status. Parasitol Today 1998;14:56-64.
2. Bloland PB, Ettling M. Making malaria-treatment policy in the face of drug resistance. Ann Trop Med Parasitol 1999;93:5-23.
3. Potkar CN, Kshirsagar NA, Kathuria R. Resurgence of malaria and drug resistance in Plasmodium falciparum and Plasmodium vivax species in Bombay. Jr Assoc Phy Ind 1995;43:336-8.
4. Garg MR, Gogtay NJ, Kotwani RN, Bodhe PV, Kshirsagar NA. Resurgence of malaria in Mumbai- is escalating chloroquine resistance a cause? J Assoc Phy Ind 1999;47:377-9.
5. Kshirsagar NA, Gogtay NJ, Garg MR, Moorthy NS, Dalvi SS, Tilve GH, Sane SP, Bhatt AD, Gahmann I, Mull R. A randomized, parallel group study of chloroquine versus coartemether for acute uncomplicated Plasmodium falciparum malaria in adults in Mumbai. Am J Trop Med Hyg 2000;62:402-8.
6. World Health Organization. Chemotherapy of malaria and resistance to anti malarials. Report of a WHO Scientific group. WHO Technical Report Series 1973:529.
7. Breckenridge AM, Winstanley PA. Clinical pharmacology and malaria. Ann Trop Med Parasitol 1997;91:727-33.
8. Honrado ER, Fungladda W, Kamoiratanaku P, Kitayaporm D, Karbwang J, Thimasam K, Masngammueng R. Cost-effectiveness analysis of artesunate and quinine-tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand. Bull World Health Org 1999;77:236-43.
9. Phillips M, Phillips-Howard P. Economic implications of resistance to antimalarial drugs. Pharmacoeconomics 1996;10:225-38.
10. Foster S, Phillips M. Economics and its contribution to the fight against malaria. Ann of Trop Med Parasitol 1998;92:391-8.
11. Schulman KA, Linas BP. Pharmacoeconomics: state of the art in 1997. Ann Rev Pub Health 1997;18:529-48.